IndSwift

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED
31st MARCH, 2007

(RS. IN LACS)

PARTICULARS	Unaudited quarter 31.03.2007	Reviewed quater 31.03.2006	Unaudited Year Ended 31.03.2007	Audited Year End 31.03.2006
Income from Operations	10312.54	5534.92	38556.60	27491.34
Others Income	18.14	16.40	134.11	128.95
TOTAL INCOME	10330.68	5551.32	38690.71	27620.29
Total Expenditure	9076.14	4882.67	33747.92	24186.29
Decrease in Stock in trade	-1505.70	-287.38	-1823.03	-516.59
Consumption of raw material	9252.45	4376.62	30060.47	20760.28
Cost of Sales	7746.75	4089.24	28237.44	20243.69
Staff Cost	368.09	228.97	1372.04	1107.36
Other expenses	961.30	564.46	4138.44	2835.24
Interest	499.89	306.56	1760.64	1093.84
Depreciation	95.15	42.20	304.85	146.48
PROFIT BEFORE TAX	659.50	319.89	2877.30	2193.68
Provision for Tax(Incl. FBT.)	83.47	41.08	355.82	214.78
Provision for Deferred Tax	80.60	153.15	292.40	252.29
Net Profit	495.43	125.66	2229.08	1726.61
Share Capital	743.57	743.57	743.57	743.57
Reserves excluding				11933.69
Revaluation Reserves EPS(Basic & Diluted)	1.33	0.34	6.00	4.64
AGGREGATE OF NON-PROMOTERS SHAREHOLDING
NUMBER OF SHARES	23985890	24056475	223985890	24056475
% OF SHARE HOLDING	64.51%	64.70%	64.51%	64.70%

NOTES:
1. During the quarter under review, the turnover of the company grew by 86.32% and profit before Tax grew by 294.26% compared to same period during previous year. 2..The Company is exclusively in the Pharmaceutical business segment. 3.Inventors complaints for quater: Openning - Nill , Received - 5, Redressed - 5, Closing Balance - Nill. 4.The above results were reviewed by the audit committee and taken on record by Board of Directors of the company by their respective meetings held on 30th April, 2007.

For and on Behalf of the Board of Directors
Sd/-


Dated: 28.04.2007		Dr.Gopal Munjal

Place: Chandigarh		Chairman